|
|
| | 1,4-DiMethyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole Basic information |
| Product Name: | 1,4-DiMethyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | | Synonyms: | 1,4-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl);1,4-DiMethyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole;1,4-DiMethylpyrazole-5-boronic Acid Pinacol Ester;1,4-dimethyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole;(1,4-DIMETHYL-1H-PYRAZOL-5-YL)BORONIC ACID PINACOL ESTER;1,4-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;1H-Pyrazole, 1,4-dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;1,4-dimethyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyra... | | CAS: | 1047644-76-7 | | MF: | C11H19BN2O2 | | MW: | 222.09 | | EINECS: | | | Product Categories: | | | Mol File: | 1047644-76-7.mol |  |
| | 1,4-DiMethyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole Chemical Properties |
| storage temp. | Inert atmosphere,Store in freezer, under -20°C | | form | solid | | Appearance | White to off-white Solid | | InChI | InChI=1S/C11H19BN2O2/c1-8-7-13-14(6)9(8)12-15-10(2,3)11(4,5)16-12/h7H,1-6H3 | | InChIKey | NOZSCXDKBYFTBH-UHFFFAOYSA-N | | SMILES | N1(C)C(B2OC(C)(C)C(C)(C)O2)=C(C)C=N1 |
| | 1,4-DiMethyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole Usage And Synthesis |
| Synthesis | General procedure for the synthesis of 1,4-dimethylpyrazole-5-boronic acid pinacol ester from 1,4-dimethylpyrazole and isopropanol pinacol borate:
1. 1,4-dimethyl-1H-pyrazole (480.0 mg, 4.993 mmol) was dissolved in tetrahydrofuran (20 mL, 300 mmol) at 0 °C and a hexane solution of 1.6 M n-butyllithium (4.7 mL, 7.5 mmol) was slowly added.
2. The reaction solution was stirred at room temperature for 1 hr and then cooled to -78 °C.
3. 2-isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (1.63 mL, 7.99 mmol) was added to the cooled reaction solution.
4. The reaction mixture was stirred at -78 °C for 0.5 h and then slowly warmed to 0 °C (0.5 h).
5. Upon completion of the reaction, the reaction was quenched with saturated saline and extracted with ethyl acetate (3×).
6. The organic phases were combined, washed with saturated brine, dried over anhydrous sodium sulfate and concentrated under reduced pressure.
7. The residue was purified by fast column chromatography using a gradient elution of ethyl acetate/hexane (0-60%).
8. Purification afforded 142 mg of the target product 1,4-dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole as a white solid. | | References | [1] Patent: WO2008/98104, 2008, A1. Location in patent: Page/Page column 90 [2] Patent: US2013/96144, 2013, A1. Location in patent: Paragraph 0171; 0172 [3] Patent: WO2014/143768, 2014, A1. Location in patent: Page/Page column 109; 110 |
| | 1,4-DiMethyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole Preparation Products And Raw materials |
|